Clinical Report: Gastric Spasm Associated with Polymyxin B: A Case Study
Background
Polymyxin B is increasingly used to treat infections caused by multidrug-resistant Gram-negative bacteria, particularly Acinetobacter baumannii. While effective, it is associated with various adverse drug reactions, necessitating careful monitoring.
Data Highlights
No numerical data or trial data were provided in the article.
Key Findings
A 14-year-old boy developed severe gastric spasm after receiving polymyxin B.
Symptoms included abdominal colic, nausea, and visible distress during treatment.
Discontinuation of polymyxin B led to significant symptom improvement.
This case highlights the need for awareness of rare adverse reactions associated with polymyxin B.
Clinical Implications
Healthcare providers should be vigilant for gastrointestinal adverse reactions in patients receiving polymyxin B, especially in pediatric populations. Discontinuation of the drug may be necessary if severe symptoms arise.
Conclusion
This case underscores the potential for polymyxin B to induce gastric spasm, warranting further investigation into its safety profile in clinical use.
